Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Goodwill: 2017-2019

Historic Goodwill for Aclaris Therapeutics (ACRS) over the last 3 years, with Dec 2019 value amounting to $18.5 million.

  • Aclaris Therapeutics' Goodwill changed negligibly% to $18.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was $18.5 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $18.5 million for FY2019, which is negligibly% changed negligibly from last year.
  • Per Aclaris Therapeutics' latest filing, its Goodwill stood at $18.5 million for FY2019, which was down 0.00% from $18.5 million recorded in FY2018.
  • Aclaris Therapeutics' 5-year Goodwill high stood at $18.5 million for FY2017, and its period low was $18.5 million during FY2017.
  • Over the past 3 years, Aclaris Therapeutics' median Goodwill value was $18.5 million (recorded in 2019), while the average stood at $18.5 million.